Deglycosylation and label-free quantitative LC-MALDI MS applied to efficient serum biomarker discovery of lung cancer
2011

Improving Lung Cancer Biomarker Discovery with Serum Deglycosylation

Sample size: 30 publication 10 minutes Evidence: high

Author Information

Author(s): Toyama Atsuhiko, Nakagawa Hidewaki, Matsuda Koichi, Ishikawa Nobuhisa, Kohno Nobuoki, Daigo Yataro, Sato Taka-Aki, Nakamura Yusuke, Ueda Koji

Primary Institution: Graduate School of Frontier Sciences, The University of Tokyo

Hypothesis

Does deglycosylation of serum proteins enhance the identification of lung cancer biomarkers using label-free quantitative mass spectrometry?

Conclusion

Deglycosylation significantly improves the quantitative performance of shotgun proteomics, aiding in the identification of unique lung cancer biomarkers.

Supporting Evidence

  • Deglycosylation improved the detection of 345 out of 2,984 peaks in serum samples.
  • 40 peptides were identified as differentially presented between healthy controls and lung cancer patients.
  • Deglycosylation resulted in a 14.3% increase in reproducibly detectable peaks.

Takeaway

This study shows that removing sugars from proteins in blood can help scientists find better markers for lung cancer.

Methodology

Serum samples were treated with enzymes to remove sugars, then analyzed using label-free quantitative mass spectrometry.

Potential Biases

Potential biases in sample selection and processing could affect the results.

Limitations

The study primarily focused on lung cancer and may not be generalizable to other cancers or conditions.

Participant Demographics

20 lung cancer patients and 10 healthy controls were included in the study.

Statistical Information

P-Value

p<0.01

Statistical Significance

p<0.01

Digital Object Identifier (DOI)

10.1186/1477-5956-9-18

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication